10-Q: Constellation Acquisition Corp I Faces Going Concern Doubt

Sentiment:

Quarterly Report


Constellation Acquisition Corp I reported a net loss for Q2 2025 and faces substantial doubt about its ability to continue as a going concern due to significant share redemptions and dwindling trust account funds.

Delay expectedThe company has repeatedly extended its deadline to complete a Business Combination, most recently to August 29, 2025, with potential for further extensions until January 29, 2026.These extensions are funded by the Sponsor through promissory notes, indicating a prolonged search for a suitable acquisition target.
Capital raiseThe Sponsor (or its affiliates/designees) provides loans to the company for working capital and to fund monthly extensions of the Business Combination deadline.The 2024 Note, a promissory note from the Sponsor, was amended on June 5, 2025, to increase its principal amount by $590,000, from $1,660,000 to $2,250,000.The 2023 Note and Extension Note, also from the Sponsor, allow for conversion of unpaid principal into warrants of the company at $1.50 per warrant.The company explicitly states it "may need to obtain additional financing either to complete an initial Business Combination or because it becomes obligated to redeem a significant number of its Public Shares upon completion of an initial Business Combination, in which case the Company may issue additional securities or incur debt in connection with such initial Business Combination."
Worse than expectedNet loss for Q2 2025 ($220,858) compared to net income for Q2 2024 ($204,957).Significant decrease in cash held in Trust Account from $28.1 million to $0.8 million.Increase in accumulated deficit to over $20.6 million.Substantial doubt about the company's ability to continue as a going concern.Critically low operating cash balance of $4,905.

Summary

  • Reported a net loss of $220,858 for the three months ended June 30, 2025, a significant decline from a net income of $204,957 in the same period of 2024.
  • For the six months ended June 30, 2025, the net loss increased to $667,766, compared to a loss of $289,193 in the prior year period.
  • Cash held in the Trust Account dramatically decreased to $815,619 as of June 30, 2025, from $28,123,011 at December 31, 2024, primarily due to substantial share redemptions.
  • Public shareholders redeemed 2,303,382 Class A ordinary shares for approximately $27,428,399 at a price of $11.91 per share on January 27, 2025.
  • The company's operating cash balance is critically low at $4,905 as of June 30, 2025, with a working capital deficit of $6,283,278.
  • The Sponsor has provided ongoing financial support through promissory notes, with $1,912,208 outstanding as of June 30, 2025, and an additional $3,181,000 in convertible promissory notes.
  • The company has extended its deadline to complete a Business Combination multiple times, now aiming for January 29, 2026, through monthly extensions funded by the Sponsor.

Sentiment

Score: 2

Explanation: The company faces severe liquidity issues, has a substantial accumulated deficit, and its trust account is nearly depleted due to high redemptions. The repeated extensions and reliance on sponsor funding, coupled with a 'going concern' warning, indicate a highly precarious financial position and significant uncertainty regarding its ability to complete a business combination.

Positives

  • General and administrative costs for the six months ended June 30, 2025, decreased to $679,774 from $1,014,201 in the same period of 2024.
  • Management has successfully extended the Business Combination deadline multiple times, providing additional time to find a target.
  • The Sponsor continues to provide financial support through loans to fund extensions and working capital.

Negatives

  • Significant net loss of $220,858 for Q2 2025, a reversal from net income in Q2 2024.
  • Substantial decrease in cash held in the Trust Account from $28.1 million to $0.8 million due to high redemptions.
  • Critically low operating cash balance of $4,905 as of June 30, 2025.
  • Working capital deficit of $6,283,278, indicating severe liquidity issues.
  • Accumulated deficit increased to $20,646,852.
  • Interest earned on Trust Account funds significantly declined due to reduced balance.
  • Shift from gain to loss in fair value of warrant liability for the six-month period.

Risks

  • Substantial doubt about the company's ability to continue as a going concern due to liquidity issues and mandatory liquidation date.
  • Inability to complete a Business Combination by the Termination Date (January 29, 2026), leading to mandatory liquidation and worthlessness of warrants.
  • Dependence on U.S. and multi-national financial institutions for banking services, with potential adverse impact from market conditions.
  • Uncertain impact of geopolitical conflicts (Russia-Ukraine war, Israel-Hamas war, China-Taiwan tensions) on the world economy and the company's financial condition.
  • Risk that the Sponsor may not be able to satisfy its indemnification obligations if claims reduce Trust Account funds.
  • Potential for insufficient funds to operate prior to a Business Combination if cost estimates are inaccurate.
  • Need for additional financing to complete a Business Combination or cover significant redemptions.
  • Warrants may expire worthless if a Business Combination is not consummated.
  • Public Warrants classified as Level 2 due to lack of trading activity, indicating potential liquidity issues for warrant holders.

Future Outlook

Management plans to consummate a Business Combination prior to the mandatory liquidation date of January 29, 2026. The company may need to obtain additional financing to complete a Business Combination or if significant redemptions occur. The company continues to extend its deadline monthly, funded by the Sponsor, to provide additional time for a Business Combination.

Management Comments

  • "Management acknowledges that the Company depends on a variety of U.S. and multi-national financial institutions for banking services. Market conditions can impact the viability of these institutions, which in effect will affect the Companys ability to maintain and provide assurances that the Company can access its cash and cash equivalents in a timely manner or at all."
  • "Management plans to consummate a Business Combination prior to the mandatory liquidation date."
  • "We intend to complete our Business Combination before the mandatory liquidation date; however, there can be no assurance that we will be able to consummate any Business Combination by the Termination Date."
  • "We do not believe that inflation had a material impact on our business, revenues or operating results during the period presented."

Industry Context

This filing reflects the typical challenges faced by Special Purpose Acquisition Companies (SPACs) in the current market environment, characterized by high redemption rates and difficulty in identifying and closing suitable business combinations within their mandated timelines. The repeated extensions and reliance on sponsor funding are common indicators of a SPAC struggling to execute its primary objective. The delisting from NYSE to OTC markets further highlights the reduced public interest and liquidity for such vehicles as their initial combination period nears expiration without a definitive target.

Comparison to Industry Standards

  • The high redemption rate of Class A shares (over 97% of initial IPO shares redeemed across multiple extension votes) is significantly higher than the average SPAC redemption rates observed in 2023-2024, which typically ranged from 70-90% for SPACs nearing their liquidation deadline without a definitive deal. This indicates a strong lack of investor confidence in the company's ability to find a suitable target or the terms of its extensions.
  • The dwindling cash in the Trust Account to $815,619, representing only 0.26% of the initial $310 million IPO proceeds, is a critical deviation from industry norms where SPACs typically maintain a substantial portion of their trust funds until a definitive business combination is announced or liquidation occurs. This low balance severely limits the size and attractiveness of any potential target.
  • The repeated reliance on sponsor loans for monthly extensions, with the 2024 Note principal increasing by $590,000 to $2,250,000, is a common but unsustainable practice for SPACs. While it provides short-term liquidity, it increases the company's liabilities to related parties and signals a prolonged search for a target, often leading to further redemptions.
  • The transition from NYSE to OTC markets (OTCQX, OTCQB, OTC Pink, OTCID) is a clear indicator of failing to meet major exchange listing requirements and a significant downgrade in market visibility and liquidity compared to other SPACs that successfully complete a de-SPAC transaction or maintain their listing while seeking a target.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Articles of AssociationOn January 27, 2023, shareholders approved an amendment to extend the Business Combination deadline from January 29, 2023, to April 29, 2023, with monthly extensions possible until January 29, 2024.2023-01-31Provided additional time for the company to identify and complete a business combination, but also led to significant redemptions.
Amendment to Articles of AssociationOn January 29, 2024, shareholders approved an amendment to extend the Business Combination deadline from January 29, 2024, to February 29, 2024, with monthly extensions possible until January 29, 2025. Also approved elimination of the net tangible assets redemption limitation.2024-01-29Further extended the timeline for a business combination and removed a barrier to redemptions, leading to more redemptions.
Amendment to Articles of AssociationOn January 27, 2025, shareholders approved an amendment to extend the Business Combination deadline from January 29, 2025, to February 28, 2025, with monthly extensions possible until January 29, 2026. Also permitted issuance of Class A shares to Class B holders upon conversion.2025-01-27Provided the latest extension for a business combination and clarified conversion rights, but resulted in further significant redemptions.
Delisting from Major ExchangeVoluntary delisting of securities from the New York Stock Exchange (NYSE) effective January 12, 2024, and subsequent listing on OTCQX, OTCQB, OTC Pink, and OTCID markets.2024-01-12Reduced market visibility and liquidity for the company's securities, typically associated with SPACs struggling to complete a business combination.

Related Party Transactions

  • Promissory notes issued to the Sponsor and certain executive officers/affiliates for working capital and extension funds, totaling $1,912,208 (non-convertible) and $3,181,000 (convertible) outstanding as of June 30, 2025.
  • Administrative service fees of $10,000 per month paid to the Sponsor for office space, utilities, and administrative support, with $300,000 reported as due to related parties as of June 30, 2025.
  • The Sponsor purchased 5,466,667 Private Placement Warrants for $8,200,000 simultaneously with the IPO.
  • The Sponsor converted 7,600,000 Class B ordinary shares into Class A ordinary shares on a one-for-one basis on January 30, 2024.
  • The Investment Agreement (January 26, 2023) involved the Investor (Endurance Constellation, LLC) agreeing to contribute up to $3,000,000 to the Old Sponsor, which was then loaned to the Company via the Extension Note.

Stakeholder Impact

  • Shareholders (Public): Significant dilution of trust account value per share due to high redemptions. Risk of warrants expiring worthless if no business combination. Reduced liquidity and market visibility due to delisting from NYSE to OTC markets.
  • Shareholders (Sponsor/Insiders): Continue to provide funding through loans, increasing their exposure. Founder shares are subject to lock-up and conversion terms tied to a business combination. Private Placement Warrants will expire worthless if no business combination.
  • Creditors: The company has substantial liabilities to related parties (Sponsor) through promissory notes. In case of liquidation, these loans are generally repaid only from funds outside the Trust Account, if any.
  • Underwriters: Entitled to a deferred underwriting discount of $10,850,000 only upon completion of a business combination, which is uncertain.

Next Steps

  • Consummate a Business Combination prior to the mandatory liquidation date of January 29, 2026.
  • Continue to draw monthly extension funds from the Sponsor to extend the Business Combination deadline.
  • Potentially seek additional financing to complete a Business Combination or manage redemptions.

Key Dates

DateDescription
2020-11-20Company incorporated in the Cayman Islands.
2020-11-23Executive officer purchased 8,625,000 Founder Shares.
2020-12-23Founder Shares transferred to the Sponsor.
2021-01-26Registration statement for IPO declared effective by SEC. Company entered into Investment Agreement with Old Sponsor and Endurance Constellation, LLC.
2021-01-29Company consummated IPO of 31,000,000 units at $10.00 per unit, generating $310,000,000 gross proceeds. Simultaneously sold 5,466,667 private placement warrants for $8,200,000. $310,000,000 placed in Trust Account.
2021-03-01Remaining 875,000 Founder Shares forfeited by the Sponsor.
2023-01-18Company issued an unsecured promissory note (2023 Note) in the amount of $230,000 to the Sponsor.
2023-01-26Old Sponsor underwent reorganization; limited partnership interests transferred to Constellation Sponsor LP (the Sponsor). Old Sponsor liquidated.
2023-01-27Extraordinary general meeting of shareholders (Extension Meeting) held to amend articles of association to extend Business Combination deadline from January 29, 2023, to April 29, 2023, with monthly extensions possible until January 29, 2024. Holders of 26,506,157 Class A shares redeemed for ~$269,485,746.
2023-01-30Control of the Sponsor transferred to affiliates of Antarctica Capital Partners, LLC. Company issued Extension Note of $3,000,000 to the Sponsor. Sponsor funded initial $450,000. Company, Old Sponsor, and Insiders amended Letter Agreement.
2023-01-31Company filed 2023 Articles Amendment with Cayman Islands Registrar of Companies.
2023-02-13$46,600,678.12 (remaining trust balance) placed in a U.S.-based trust account at Citibank, N.A.
2023-04-28Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to May 29, 2023.
2023-05-26Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to July 3, 2023.
2023-07-03Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to July 28, 2023.
2023-07-28Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to August 29, 2023.
2023-08-29Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to September 29, 2023.
2023-09-29Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to October 29, 2023.
2023-10-26Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to November 28, 2023.
2023-11-28Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to December 29, 2023.
2023-12-20Board approved voluntary delisting from NYSE. Company announced intention to delist from NYSE and apply for OTCQX listing.
2023-12-28Company drew $150,000 from Extension Note, deposited into Trust Account, extending deadline to January 29, 2024.
2024-01-02Company filed Form 25 with SEC to effect delisting from NYSE.
2024-01-12Delisting from NYSE became effective. Last day of trading on NYSE.
2024-01-16Securities began trading on OTCQX (Class A & Units on OTCQB, Warrants on OTC Venture).
2024-01-23Extraordinary general meeting adjourned to January 25, 2024.
2024-01-25Extraordinary general meeting adjourned to January 29, 2024.
2024-01-292024 Shareholder Meeting held to extend Business Combination deadline from January 29, 2024, to February 29, 2024, with monthly extensions possible until January 29, 2025. Also approved elimination of redemption limitation. Holders of 2,126,159 Class A shares redeemed for ~$23,671,533.
2024-01-30Company filed 2024 Articles Amendment. Sponsor converted 7,600,000 Class B ordinary shares into Class A ordinary shares. Company issued 2024 Note in the amount of $1,660,000 to the Sponsor.
2024-02-29Company drew $55,000 for First 2024 Extension (to March 29, 2024).
2024-03-28Company drew $55,000 for Second 2024 Extension (to April 29, 2024).
2024-04-29Company drew $55,000 for Third 2024 Extension (to May 29, 2024).
2024-05-29Company drew $55,000 for Fourth 2024 Extension (to June 29, 2024).
2024-06-28Company drew $55,000 for Fifth 2024 Extension (to July 29, 2024).
2024-07-23Company drew $55,000 for Sixth 2024 Extension (to August 29, 2024).
2024-08-23Company drew $55,000 for Seventh 2024 Extension (to September 29, 2024).
2024-09-26Company drew $55,000 for Eighth 2024 Extension (to October 29, 2024).
2024-10-29Company drew $55,000 for Ninth 2024 Extension (to November 29, 2024).
2024-11-27Company drew $55,000 for Tenth 2024 Extension (to December 29, 2024).
2024-12-20Company drew $55,000 for Eleventh 2024 Extension (to January 29, 2025).
2025-01-272025 Shareholder Meeting held to extend Business Combination deadline from January 29, 2025, to February 28, 2025, with monthly extensions possible until January 29, 2026. Also permitted issuance of Class A shares to Class B holders upon conversion. Holders of 2,303,382 Class A shares redeemed for ~$27,428,399.
2025-02-25Company drew $5,000 for First 2025 Extension (to March 29, 2025).
2025-03-10Company's Class A ordinary shares started trading on OTC Pink Market and Units on OTCQB.
2025-03-27Company drew additional Extension Funds for Second 2025 Extension (to April 29, 2025).
2025-04-29Company drew additional Extension Funds for Third 2025 Extension (to May 29, 2025).
2025-05-28Company drew additional Extension Funds for Fourth 2025 Extension (to June 29, 2025).
2025-06-05Company amended the 2024 Note, increasing principal by $590,000 from $1,660,000 to $2,250,000.
2025-06-26Company drew additional Extension Funds for Fifth 2025 Extension (to July 29, 2025).
2025-06-30End of current reporting period.
2025-07-16Company's Public Warrants and Units started trading on OTCID Basic Market.
2025-07-28Company drew additional Extension Funds for Sixth 2025 Extension (to August 29, 2025).
2025-08-12Date of filing of this Quarterly Report on Form 10-Q.
2025-08-29Current extended deadline for Business Combination (Sixth 2025 Extension).
2026-01-29Latest possible Termination Date for Business Combination, if all extensions are exercised.

Recommendation

sell

The company is in a highly distressed state, evidenced by a 'going concern' warning, critically low operating cash, a near-depleted trust account due to massive redemptions, and a significant accumulated deficit. Its repeated reliance on sponsor loans for extensions highlights a failure to secure a viable business combination. The delisting from NYSE to OTC markets further diminishes liquidity and investor confidence. Given the high risk of liquidation without a business combination and the potential for warrants to expire worthless, a seasoned investor would likely recommend selling to minimize further losses.

Keywords

SPAC, Blank Check Company, SEC Filing, 10-Q, Quarterly Report, Business Combination, Trust Account, Redemptions, Going Concern, Liquidity, Warrants, Corporate Governance, Financial Reporting, CSTAF

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.